Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
0.3252
-0.0074 (-2.22%)
Jun 18, 2025, 2:28 PM - Market open

Catheter Precision Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.480.420.440.010.020.26
Revenue Growth (YoY)
9.57%-4.98%3057.14%-36.36%-91.51%-
Cost of Revenue
0.050.040.030.161.562.17
Gross Profit
0.430.380.41-0.15-1.54-1.91
Selling, General & Admin
12.1811.3517.1216.2515.4824.53
Research & Development
0.340.270.486.3912.258.96
Operating Expenses
12.5211.6217.622.6427.7333.49
Operating Income
-12.08-11.24-17.19-22.79-29.27-35.4
Interest Expense
-0.14-0.09----
Interest & Investment Income
0.070.080.35---
Other Non Operating Income (Expenses)
-3.32-2.257.20.1-0.010.09
EBT Excluding Unusual Items
-15.48-13.5-9.64-22.69-29.28-35.31
Merger & Restructuring Charges
----4.17--
Impairment of Goodwill
---60.93---
Other Unusual Items
----2.02-
Pretax Income
-15.6-13.5-70.57-26.86-27.26-35.31
Income Tax Expense
2.423.14-000.01
Earnings From Continuing Operations
-18.01-16.64-70.57-26.87-27.26-35.32
Earnings From Discontinued Operations
----2.19-0.73
Net Income
-18.01-16.64-70.57-26.87-25.07-36.05
Preferred Dividends & Other Adjustments
5.165.160.8---
Net Income to Common
-23.17-21.8-71.37-26.87-25.07-36.05
Shares Outstanding (Basic)
63100-
Shares Outstanding (Diluted)
63100-
Shares Change (YoY)
784.28%493.91%431.53%923.58%--
EPS (Basic)
-3.93-6.68-129.88-259.86-2482.18-
EPS (Diluted)
-3.93-6.68-129.88-259.86-2482.18-
Free Cash Flow
-9.72-9.34-20.7-22.59-27.89-28.37
Free Cash Flow Per Share
-1.65-2.86-37.66-218.46-2761.39-
Gross Margin
90.02%90.00%93.21%---
Operating Margin
-2512.06%-2676.91%-3888.01%-162778.57%-133027.27%-13668.34%
Profit Margin
-4817.26%-5190.71%-16147.51%-191892.86%-113954.55%-13916.99%
Free Cash Flow Margin
-2021.21%-2223.33%-4682.13%-161321.43%-126772.73%-10954.05%
EBITDA
-9.97-9.13-15.11-22.37-28.1-33.44
D&A For EBITDA
2.122.112.080.421.171.97
EBIT
-12.08-11.24-17.19-22.79-29.27-35.4
Revenue as Reported
-----0.26
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q